Roblox Corp (NYSE:RBLX) was a sale that we got stopped out on. We bought the stock initially in the 50s. We got stopped out at 126.

Any eligible IP holder can offer content for use on Roblox after debuting with a select number of partners earlier this year ...

Plants Vs Brainrots is a Roblox experience where your plants defend your base against powerful brainrot characters. This tycoon-style simulator allows you to place defeated Brainrots on your base to ...

But while the current conversation around the stock focuses largely on quarterly bookings and margin pressures, the more interesting question is what Roblox will look like in five years. Because ...

Fortnite creators can now sell items and access inside their maps for V-Bucks, marking a major shift toward Roblox-style ...

On October 23, 2025, Roblox launched a platform-wide event called Roblox Halloween Spotlight. It is being held in the Cursed Clearing village, which has four game lobbies. Players can solve multiple ...

Starting with the easiest, but most unlikely solution is simply downloading Roblox from the Google Play Store. It’s a hit-or-miss (but mostly a miss) option because nine times out of 10 the Google ...

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of October 27-31. Take advantage of ...

Saturday morning pick up golf with my contemporaries usually includes the question, “Are you still working?” It’s a polite way to gauge whether the older guy you are playing with is retired. But in ...

TALLAHASSEE, Fla — Florida Attorney General James Uthmeier is issuing criminal subpoenas to the popular gaming platform Roblox. In a post on social media, Uthmeier says, “Roblox profited off out kids ...

View post: Stylish 2025 Hyundai Kona Electric Gets Hot Lease Deals for November Autoblog aims to feature only the best products and services. If you buy something via one of our links, we may earn a ...

AstraZeneca Plc got a rare sell rating on Thursday as Deutsche Bank AG analysts downgraded the British drugmaker, taking a more skeptical view on the company’s drug pipeline, in particular for breast ...